Preparation and evaluation of gastroretentive floating tablets of Silymarin

Chemical and Pharmaceutical Bulletin

Volumn 57, Issue 6, 2009, Pages 545-549

  Garg, Rajeev ^a   Gupta, Ghanshyam Das ^a  

^a Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy   (India)

Author keywords

Crospovidone; Floating; Gastroretentive; Microcrystalline cellulose; Polypropylene foam powder; Silymarin

Indexed keywords

ALGINIC ACID; BICARBONATE; CARBOMER; CITRIC ACID; HYDROXYPROPYLMETHYLCELLULOSE; MICROCRYSTALLINE CELLULOSE; POLYPROPYLENE; SILYMARIN; XANTHAN;

ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG RELEASE; DRUG RETENTION; DRUG SCREENING; DRUG SOLUBILITY; DRUG SYNTHESIS; IN VITRO STUDY; PATIENT COMPLIANCE; TABLET FORMULATION;

ANTIOXIDANTS; BETA-CYCLODEXTRINS; BIOLOGICAL AVAILABILITY; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HALF-LIFE; LIVER; METHYLCELLULOSE; SILYMARIN; SOLUBILITY; STOMACH; TABLETS; WATER;

EID: 66949121840     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.57.545     Document Type: Article

References (34)

1. Choi B. Y., Fark H. J., Hwang S. J., Park J. B., Int. J. Pharm., 239, 81-91 (2002).
2. Streubel A., Siepmann J., Bodmeier R., Expert Opin. Drug Deliv., 3, 217-233 (2006).
3. Ali J., Arora S., Khar R. K., AAPS PharmSciTech, 6, E372-E390 (2005).
4. Ponchel G., Irache J. M., Adv. Drug Del. Rev., 34, 191-219 (1998).
5. Deshpande A. A., Shah N. H., Rhodes C. T., Malick W., Pharm. Res., 14, 815-819 (1997).
6. Davis S. S., Stockwell A. F., Taylor M. J., Pharm. Res., 3, 208-213 (1986).
7. Klausner E. A., Lavy E., Friedman M., Hoffman A., J. Controlled Release, 90, 143-162 (2003).
8. Kedzierewicz F., Thouvenot P., Lemut J., Etienne A., Hoffman M., Maincent P., J. Controlled Release, 58, 195-205 (1999).
9. Groning R., Heun G., Drug Dev. Ind. Pharm., 10, 527-539 (1984).
10. Chawala G., Bansal A., Pharm. Technol., 27, 50-68 (2003).
11. Singh B. N., Kim K. H., J. Controlled Release, 63, 235-239 (2000).
12. Muriel P., Mourelle M., J. Appl. Toxicol., 10, 275 (1990).
13. Sonnenbichler J., Zetl I., Progr. Clin. Biol. Res., 213, 319-331 (1986).
14. Parfitt K., Martindale, "The Complete Drug Reference," 32nd ed., 1999, pp. 993-994.
15. Qiu M., Jia W., Li S., Xu Z., Sun X., Wang X., Zhang Y., Xie G., Adv. Ther., 22, 595-600 (2005).
16. Baumgartner S., Kristl J., Vrecez F., Vodopivee P., Zorko B., Int. J. Pharm., 195, 125-135 (2000).
17. Gerogiannis V. S., Rekkas D. M., Dallas P. P., Choulis N. H., Drug Dev. Ind. Pharm., 19, 1061-1081 (1993).
18. Nakhat P. D., Naidu R. A., Babla I. B., Khan S., Yeole P. G., Ind. J. Pharm. Sci., 69, 287-289 (2007).
19. "The United State Pharmacopoeia XXIV, United State Pharmacopoeial Convention," Rock Ville, 2000, pp. 1941-1943.
20. Jaimini M., Rana A. C., Tanwar Y. S., Curr. Drug Deliv., 4, 51-55 (2007).
21. Chavanpatil M., Jain P., Chaudhari S., Shear R., Vavia P., Int. J. Pharm., 304, 178-184 (2005).
22. O'Connor R. E., Schwartz J. B., Pharm. Res., 10, 356-361 (1993).
23. Rahman Z., Ali M., Khar R. K., Acta Pharm., 56, 49-57 (2006).
24. Siepmann J., Podual K., Sriwongjanya M., Peppas N. A., Bodmeier R., J. Pharm. Sci., 88, 65-72 (1999).
25. Chavanpatil M., Jain P., Chaudhari S., Shear R., Vavia P., Int. J. Pharm., 316, 86-92 (2006).
26. Kitagawa S., Nakayama T., Isono M., U.S. Patent 4766159 (1988).
27. Sung K. C., Nixon P. R., Skoug J. W., Ju T. R., Gao P., Topp E. M., Patel M. V., Int. J. Pharm., 142, 53-60 (1996).
28. Ju R., Nixon P. R., Patel M. V., J. Pharm. Sci., 84, 1455-1463 (1995).
29. Giunchedi P., Gavini E., Moretti M. D. L., Pirisino G., AAPS PharmSciTech, 1, 19 (2000).
30. Baveja S. K., Ranga Rao K. V., Devi P., Int. J. Pharm., 39, 435 (1987).
31. Wagner J. G., J. Pharm. Sci., 58, 1253 (1969).
32. Higuchi W. I., J. Pharm. Sci., 52, 1145 (1963).
33. Korsmeyer R. W., Gurny R., Doelker E., Buri P., Peppas N. A., Int. J. Pharm., 15, 25 (1983).
34. Siepmann J., Peppas N. A., Adv. Drug Del. Rev., 48, 139-157 (2001).